HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sun, X. Articles by Kang, Y. J. Search for Related Content PubMed PubMed Citation Articles by Sun, X. Articles by Kang, Y. J.

---

ORIGINAL ARTICLE

Prior Increase in Metallothionein Levels Is Required to Prevent Doxorubicin Cardiotoxicity¹

Xiuhua Sun^* and Y. James Kang^*,#,,2

^* Departments of Medicine and
^# Pharmacology and Toxicology, University of Louisville School of Medicine, and
Jewish Hospital Heart and Lung Institute, Louisville, Kentucky 40202

Many studies have shown that metallothionein (MT) can be increased significantly by different oxidative insults in multiple organ systems. However, the increase in MT production often fails to protect against oxidative tissue injury. On the other hand, recent studies using a cardiac-specific, MT-overexpressing, transgenic mouse model have shown that MT protects against oxidative heart injury. Thus, the present study was undertaken to test the hypothesis that prior increase in MT levels is required to prevent oxidative injury. Oxidative heart injury was induced by doxorubicin (DOX), an important anticancer drug that causes severe cardiotoxicity through oxidative stress. Cardiac-specific, MT-overexpressing, transgenic mice and wild-type (WT) FVB mice were treated with DOX at 20 mg/kg. Four days after the treatment, MT concentrations were markedly elevated in the WT mouse heart. The elevated MT concentrations were comparable with those found in the transgenic mouse heart, which did not show further MT elevation in response to DOX challenge. Severe oxidative injury occurred in the heart of WT mice, including myocardial lipid peroxidation, morphological changes as examined by electron microscopy, high levels of serum creatine kinase activity, and decreased total glutathione concentrations in the heart. However, all of these pathological changes were significantly inhibited in the MT-transgenic mice. Therefore, this study demonstrates that there is a correlation between MT induction and oxidative stress in the DOX-treated mouse heart. However, MT can protect the heart from oxidative injury only if it is present prior to induction of oxidative stress.

Key Words: cardiomyopathy • creatine phosphokinase • doxorubicin • ultrastructural alterations • transgenic mice

This article has been cited by other articles:

				W. Feng, F. W. Benz, J. Cai, W. M. Pierce, and Y. J. Kang Metallothionein Disulfides Are Present in Metallothionein-overexpressing Transgenic Mouse Heart and Increase under Conditions of Oxidative Stress J. Biol. Chem., January 13, 2006; 281(2): 681 - 687. [Abstract] [Full Text] [PDF]

				A. J. Chicco, C. M. Schneider, and R. Hayward Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R424 - R431. [Abstract] [Full Text] [PDF]

				S. FOGLI, P. NIERI, and M. C. BRESCHI The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage FASEB J, April 1, 2004; 18(6): 664 - 675. [Abstract] [Full Text] [PDF]